Clinical Trial Results: Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B [Phase 3]

View source ↗

Summary

Phase 3 trial results for PF-06741086 in adults and adolescents with severe Hemophilia A or moderately to severely severe Hemophilia B; study completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia
• Hemophilia B

Drugs mentioned

• PF-06741086

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A, Hemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2026-08-14